§ HRT men, Testosterone
Benefits (7
pages) LINKS
http://healthfully.org/rc/id7.html
/male hormones
1/28/22
The state of
medical science is worse than imagined.
For exposes on bad pharma read, Marketing
Science, Side
Effects, and Junk treatments . Testosterone (TTT) usage has come under attack
by pharma and the FDA for the sake of pharma’s profits. The FDA issued a
black-box warning for TTT exposure
of children by contact with a user.[1] Pharma attacks TTT (which is not patented)
for causing aggressive prostate cancer and Cardio-Vascular Disease (CVD);
both are not
just false, the opposite
is true--see next page.
Keeping the youthful level of TTT has major health benefits for both men past
60 and women past
50. [2]
The testicles
produce 95% of the TTT, about 5 mg/day & about 50 to
100 mcg of estradiol and dihydrotestosterone
(DHT).
In women TTT is synthesized
by the corpus luteum (adjacent to the ovaries) and the adrenal cortex--TTT’s
level is about 1/7th
of a man’s, and it is more bioactive. TTT is 60% bonded to
a plasma protein, 38% to albumin, and 2% free.
DHT and TTT are androgens
and thus build muscle mass. DHT is 3-5 times more potent than testosterone or other
androgens (except in skeletal muscle tissue, where testosterone is the main
androgen).
TTT & DHT freely enters target cells and binds to intracellular receptors
which then bind to DNA promoting gene transcription. DHT
is more active at these sites. DHT
is necessary in early development for enlargement of the prostate, penis,
and hair growth at the time of puberty. The pituitary gland secretes LH
and FSH; they act on the testes to stimulate the production of sperm and TTT.
Estrogen (estradiol) is a vital component
of the male physiology, and in fact is made from TTT. Estrogen decreases
LH production and thus TTT.
The normal range for TTT is 13 - 40 nmol/L (370 - 1100 ng/dL), and for
estradiol is 55 -165 pmol (10 - 30 ng/dL)--the first is the high levels for
80-year old man followed high level for a 20-year old. “Although, this doesn't automatically mean that a young man
with 380 ng/dL has the same amount of testosterone of an 80+ year old,
since there is usually a big difference in SHBG levels in the bloodstream
between young and elderly, resulting in a much higher free testosterone level
in the young…” Wiki , and. The bioactivity of
TTT declines significantly with age, at--like so much
else serum TTT has declined over40% in the last 100 years, reason
unknown—JK guess for cause is estrogen & TTT mimics of which soy protein is
the best researched.[3]
Noticeable improvements
with topical
testosterone,
timeline to significant improvement—(Eur
J Endocrinol. 2011,
Nov. 675-85)
Sexual interest 6 weeks Erection/ejaculation 26 weeks
Quality of life 4+ weeks
Depressed mood 30 weeks
Erythropoiesis-red cells 52
weeks Lipid profile 52 weeks
Insulin sensitivity 52 weeks
Muscle strength 16 weeks
Reduced fat mass 16
weeks Reduced inflammation
12 weeks Bone mass detectable at 6 weeks
(versus gradual erosion, prevents osteoporosis). Same benefits findings at.
“A
new concept of the role of testosterone in
male physiology suggests that testosterone plays also a significant role in the
development and maintenance of bone and muscle mass and is a determinant of
glucose homeostasis and lipid metabolism…. Treatment of testosterone deficiency
is to become part and parcel of this approach”, at 2008.
[1] TTT is made both by girls
and boys, pre-puberty. The FDA used 8 cases of reported aggression
or early genitalia enlargement as the reason for the black-box warning; just
that their father took TTT supplement.
There was no laboratory investigation of the children to prove that
those events were caused by contact with their father, rather than natural precocious puberty.
[2]
Pharma does marketing science to “show” e.g.
that TTT doesn’t prevent CVD,
insulin resistance, etc. by using too low a dose of TTT. For example a Mayo Clinic study
used “transdermal testosterone patch (50 mg per day; D-TRANS, by
Alza (J&J). The 2 lead authors were
opinion leaders for 5 pharma companies.
JK, age 72, applies 150 mg TTT
cream. Androgel 1.62, 2 pumps (30 days)
= 40.5 mg/day for ~$420. When TTT
therapy became popular, pharma
attacked its usage. Trials that don’t
obtain a serum level of 580 ng/dL have not produced a TTT level comparable to
that of a 60 year old in 1920—see JECM 2007 –thus won’t show full benefits.
[3]
Kaayla Daniel, PhD, The Whole Soy Story;
it is a protease inhibitor, has phytates,
oxalates, and is an estrogen mimic blocking TTT.
Mitochondrial
dysfunction: This
explains all the benefits below!
Mitochondria have sex steroids (including DHEA) that turn up the various
processes that protect the mitochondria from damage by reactive oxygen and
reactive nitrogen species. Optimal
mitochondrial functions entail an adequate supply of the energy molecule ATP,
which is what fats and carbohydrates are used to make through their conversion
acetyl-CoA and pyruvate in the cytosol and then transported into the
mitochondria to make the essential ATP.
EVERY PROCESS IN THE BODY RUNS ON ATP. Early in 2018, I came to the realization
that the long list of conditions associated with the western diet had as a
starting point the reactive sugar fructose damages mitochondrial DNA. Subsequent
investigation found that the sex
hormones TTT and estradiol are mitochondrial protective from reactive
chemicals, and this is the mechanism behind their long list of benefits. “Both
steroids trigger a complex molecular mechanism that involves crosstalk between
the mitochondria, nucleus, and the smooth and rough endoplasmic reticulum. The
result of this signaling is mitochondrial protection”, at Sept 2013. “Our results indicate that
testosterone improves cell survival
and mitochondrial membrane potential and reduces nuclear fragmentation and
reactive oxygen species (ROS) generation. These effects were accompanied by a
positive regulation of neuroglobin, an oxygen-binding and sensor protein, which
may serve as a regulator of ROS and nitrogen reactive species (NOS), . . . these findings suggest that astroglia may
mediate some of the protective actions of testosterone in the brain upon
pathological conditions.” At
June 2016 and similar for cyto-protection and cardiac recovery after MI, at 2004. The mitochondria convert ADP to ATP,
which
provides 90% of the energy used in the body (source is fats and glucose). By
TTT protecting the mitochondria more ATP
is made, which among other things powers the processes known as autophagy (healing)n
process on a
cellular level. The decline in the rate
of mitochondria and thus autophagy explains why the elderly have so many health
issues, and why TTT & DHEA supplement for men have so many varied health
benefits.[1] Unfortunately, the pharma is in the business
of treating illness and of education, thus through their Key Opinion Leaders (KOLs)
pharma creates opposes steroid supplements as does their
dupes, the pill pushers.
Alzheimer’s (AD) and
Parkinson’s Diseases: “Beta amyloid accumulation in the brain is the physical manifestation
for AD.
TTT decreases amyloid
secretion from rat cortical neurons15 and reduces amyloid-induced
neurotoxicity in cultured hippocampal neurons”16 Moffat, and,
“TTT reduces neuronal secretion
of Alzheimer's β-amyloid [Aβ]
peptides.” Based on in vitro study a
decrease in Aβ release was observed. “[L]ong-term testosterone
concentrations
in individuals prior to the diagnosis of dementia.… The results of this study
revealed an approximate 10% reduction in the risk for AD for each unit increase
in free testosterone. Moffat; a 26% decrease for each 10-nmol
FTI increase.
at and, at, and. Method
through modifying APOE
genotype and BRACE1. Parkinson’s Disease, TTT improves function, patient deficiency. A study of
hypoxia and DHEA, TTT, and estradiol and their metabolite epiandrosterone
(EPIA) found EPIA neuro-protective.
Andropause, the condition of low TTT which is
symptomatic including loss of muscle mass & libido, depression, increased
abdominal fat, MeS, insulin
resistance all of which come on slowly and often are not addressed by TTT treatment significantly improved symptoms.
Arthritis:
Significantly reduced levels
of serum free testosterone were found in
the RA group [rheumatoid arthritis compared to osteoporosis group], BMJ
Jan 1988. “Free and serum testosterone levels were
significantly lower in the RA males than in either the AS [ankylosing
spondylitis] group or the healthy controls” Clinical
rheumatology 1989.
Cancer,
Since TTT promotes
overall health and exercise, and those
who are most fit have a lower risk of developing cancer. This possible needs
investigation
“Testosterone exerts pro-apoptotic [cell death] effects in prostate and colon
cancer cells through membrane-initiated mechanism.” at
2013. Elevated sex hormones through the apoptosis
system of dismantling defective cells lowers the risk for cancer, at 2011
Breast Cancer, reduces risk of
breast cancer in women by stimulating immune system, and occupies ER receptors
on the breast thereby preventing estrogens attaching there. Kathy Maupin, The
Secret of Female Hormone P 165. Also
2015, 2009, 2009,.and 2004, for metastatic
2014. Population studies are flawed because of
obesity causing increased estrogens. The
obese are insulin resistance which increases all cancer-type risks. Insulin
resistance is the confounding
variable.
Prostate Cancer: Low levels of TTT are
associated with both higher risk and disease progression.
“In our study patients with prostate
cancer and
low free TTT had more extensive
disease”, also, also. “This finding suggests that low serum free TTT may
be a marker for
more aggressive disease.” This evidence
calls to question chemical castration
for prostate cancer. The theory that TTT
regulates in later life the growth
of the prostate organ is without valid
support. Like the penis, the window for
growth closes after puberty. Both organs
are a result of DHT not TTT.
Moreover, TTT is only
essential for prostatic secretion; not its growth. Harvard Medical School and
Prof. Abraham
Morgentaler MD, Testosterone for Life, p.
115-139 reviews the source (Dr.
Huggins). They found the work junk
science, and not supported by subsequent journal articles. Very low TTT from
castration slows the rate
of growth and giving a TTT supplement subsequently stimulates growth. Only those
who had very low testosterone,
such as those who as part of the treatment for prostate cancer experience this
effect. However, for those with normal
TTT supplement doesn’t accelerate growth.
Huggins and latter Fowler and Whitmore demonstrated what Prof. Morgentaler
calls “testosterone flare”
P. 129-131, also.
A that study measured TTT in the prostates showed that with normal level
the prostate dose not adsorb more. It is like thirst, once enough more TTT isn’t
adsorb. That is why though TTT
supplement for those with normal level don’t experience an accelerated rate of
prostate cancer growth. In fact, those
with high serum TTT are at significantly lower risk. The use of TTT in all men
as it declines with
age below 450
ng/dL, would lower their risk.
Cardiovascular
Disease (CVD), Metabolic Syndrome (MeS) , atherogenesis, MI, high cholesterol,
obesity, & blood glucose: Numerous
studies link
obesity to low TTT,
atherosclerosis,
to obesity, at,
and
hypertension, and TTT administered improves those with MeS, at. TTT
treatment results in weight loss, at. “Emerging evidence
suggests that testosterone therapy may be able to reverse some aspects of
metabolic syndrome” metastudy,
and. And another: “These
results suggest that low SHBG [sex hormone-binding globulin] and/or AD
[androgen deficiency, TTT] may
provide early warning signs for cardiovascular risk and an opportunity for early intervention
in non-obese men.”
In a matched study followed ten years published by the AHA found that
the
lowest quarter of men were 41% more likely to die from cancer and
cardiovascular disease compared to the highest quarter. Low TTT is associated with cardiovascular
disease. TTT Inhibits
atherogenesis: in a survey paper,
“Positive correlation between total or free testosterone level and HDL
and a negative association the LDL” and. Conclusion:
“A normal physiological level of TTT
in men protects against the development of high cholesterol, insulin resistance, hypertensions,
clots that cause heart
attacks, obesity, and increased waist:hip ratio, all of which predispose to the
development of CVD. Low or low normal TTT
is implicated in the pathogenesis
of acute MI and acute stroke. The
decline of TTT with age may explain
the greater risk of CVD with
advancing years” and [medical terminology simplified by jk]. TTT
promotes through cardiac mitochondria protection a better outcome following an
MI, at 2004. A
literature-review study
confirms TTT positive effects upon
vascular functions--2012. After
controlling for factors
low TTT associated with MI, positive effect upon fibrinolytic pathway, reduces angina.
Current claims counter this are based on recent marketing studies, and
a July 2014 Lancet article contradicts those findings, and 2008.
“Testosterone induces
cyto-protection by activating ATP-sensitive K+ channels in cardiac
mitochondrial inner membrane,” FULL at 2004.
TTT is good for your heart (2013 review) & health, but not for pharma, who
with NIH goes after its usage. “This result could suggest that the development of cardiovascular disease after menopause is
due not
only to estrogen decline but also to androgen decline. More studies are needed
to evaluate the role of androgen replacement therapy on postmenopausal women
with low level of this hormone” at 2007. The heart is a muscle, and TTT builds muscle,
ergo, it lowers MI in both men and women.
Endothelial cell dysfunction prevented,
the compromised performance of the single layer of squamous cells lining all
the blood that form an interface between circulating blood content and interior
tissue. Endothelial dysfunction (the
gateway) is responsible for over 95% of all cardiovascular disease. Estradiol
significant improves the
performance of these cells. Low TTT is
associated with endothelial dysfunction, 2007
Cognitive Function: “Several observations suggest that
testosterone is also capable of modulating neural systems in adult animals. For
example, androgen treatment prevents N-methyl- D-aspartate (NMDA)
excite-toxicity in hippocampal neurons12 and may facilitate recovery
after injury by promoting fiber outgrowth and sprouting.13 Administration of TTT increases nerve growth factor
(NGF) levels in the hippocampus,
and induces an up-regulation of NGF receptors in the forebrain. TTT
was protective of human primary neurons in culture, providing the most direct
evidence for neuro-protective effects of TTT
on human neural tissue”(Moffat), widely supported.
Equivocal finding are because of the study’s design. TTT
reduces the rate of age-related
cognitive
decline.
Neurosteroids,
are
produced locally in the brain; they promote brain health in the aging
population, they turn up autophagy, the cells healing and replacement processes
at 2012,
2019. “Of neurosteroids as modulators
of brain function. This review considers potential mechanisms contributing to
antidepressant and anxiolytic effects of allopregnanolone and other GABAergic neurosteroids
2019. “Multiple studies have been
conducted so
far to show efficacy of neurosteroids” Full
seminal. Autophagy turns up the production
of TTT by promoting cholesterol uptake, full 2018
Diabetes and
insulin resistance: Multiple studies found that type-2 diabetes
associated with low TTT, and lowest TTT
diabetes have double the death rate
at, insulin role. After one year on TTT exercise and diet 81% improved, vs
31% for those without TTT, also, &.
“Low testosterone precedes elevated fasting insulin, glucose, and
hemoglobin A1c (HbA1C) values and may even predict the onset of diabetes.
Treatment of prostate cancer patients with surgical or medical castration
exacerbates IR and glycemic control,” at 2009, and
replacement TTT improves survival,
at 2013. Insulin resistance is strongly associated
with CVD, and inflammation, and
anti-inflammatory action reduces IR
at 2003.
Metabolic syndrome a collection of markers for fructose
induced insulin resistance has been grouped into metabolic syndrome. They are
caused by the high-fructose western diet which causes much more when
compared to those life-long on a low sugar diet. Even so, the risk of MeS is
less with
adequate TTT and much higher when elderly.
“The metabolic syndrome is associated
with lower-than-normal testosterone levels” at 2008, treatment with TTT, 2005, and 2009.
Mitochondria a big piece of the puzzle for why TTT and E2 (estradiol)
have a wide
spectrum of benefits is because of receptors in the mitochondria.
Simply put at the heart of our current health disaster (known as conditions
associated with the western diet) is damage to the mitochondria which produce our
energy molecule ATP.
Reduced rate of metabolism of glucose from
dysfunction causes in resistance a major cause for age related conditions in
part by causing low TTT and insulin
and leptin resistance.. Nature does
function to make us sick, and with aging the level of these hormones and DHEA
decline precipitously, significantly more than populations on a low sugar
diet. The combination of accelerated
decline in mitochondrial functions is the most significant pathogenic
consequence of our high fructose diet.
Part of that process involves the steroids, and thus to raise them to a
youthful level or to be in the top of your age group, improves mitochondrial
functions. Nature functions to keep us
health and cull the aged from the tribal group; elevation of these hormones
slow that process. “Both steroids
trigger a complex molecular mechanism that involves crosstalk between the
mitochondria, nucleus, and plasma membrane, and the cytoskeleton plays a key
role in these interactions. The result of this signaling is mitochondrial
protection’ at
2013. “Testosterone levels were positively correlated with insulin
sensitivity” 2005.
Mood elevation, cognitive functions, mental & physical well-being
& sexual drive: with all these positive effects both quality
of life and mood elevation improve. DHT
& its metabolites have powerful euphoriant,
libido, anti-anxiety, & antidepressant effects. As stated before benefits
are dose related,
and they come on slowly over a period of one year. It is NOT
a coincidence that as the TTT level
drops with age that numerous age-related conditions develop and the quality of
life decreases. Sexual performance
and drive improves mainly because of increased strength, endurance, & mental
alertness, i.e., general well-being. Quality study at 18 years found
the lowest 1/3rd had a 33% greater death rate. At youthful level TTT dramatically improves health,
quality, and duration of
life. Through protection of
mitochondria, and thus increased ATP, TTT improves cognitive function see 2016
Neurosteroids: (HEALTHY
BRAIN): “These brain-mainly glia
cells produces sex steroids that are labeled “neurosteroids”, and have been
found to exert important regulatory functions” at
2008. I have I have extensively reviewed the
literature on pregnenolone, estradiol, testosterone,
and DHEA and their storage
form such as DHEAS and pregnenolone sulfate and their supplement explains their
benefits for many age related neurodegenerative conditions is the best
treatment (contrary to pharma’s warnings). Nature
doesn’t evolve their bio-usages contrary to village survival.
Osteoporosis & bone density:
“The most significant increase in BMD [bone mass density] was seen during the first year of TTT treatment in previously untreated
patients, when BMD increased from 95.2 ± 5.9 to 120.0 ± 6.1
mg/cm3 hydroxyapatite (mean ± SE).
Long term TTT treatment
maintained BMD
in the age-dependent reference range in all 72 hypogonadal
men….” Protects against rheumatoid
arthritis. Low TTT associated with RH. TTT
encourages bone marrow stimulation and reversing the effects of anemia.
Sarcopenia
refers to the loss of skeletal muscle mass with age and is associated with low
levels of TTT. “We have found a
prevalence of sarcopenia of 22.6%
in
older postmenopausal women
not receiving estrogen.” TTT
prevents
and reverses sarcopenia
in men and women through the
simulation of the growth differentiation factor & lowering myostatin.
Strength-weight (improved
lean body mass
to fat ratio) and obesity:
Study shows that 65 years of age men lost 3 kg of fat
while gaining 1.9 kg of muscle mass over a 36 month period. “After
3 months of TTT treatment, lean body mass was significantly
increased”,… Muscle adaptation to exercise
is
strongly influenced by anabolic endocrine hormones … whereas TTT and locally expressed
IGF-I
have been reported to activate muscle stem cells. Several studies have reported
… maximal voluntary
strength in healthy older men.” “It is known that plasma total
testosterone (T) is decreased in obese men in proportion to the degree of
obesity,” Not just TTT, muscle growth depends on usage.
Skin
healthier: “The implication
of this finding is that oestrogen or
testosterone, or both, prevents the
decrease in skin collagen content that occurs with aging and protects skin
in the same way as it protects bone in postmenopausal women.” Brincat 1983. The focus of research on TTT is on application
of transdermal patches, not skin health; however, since there is ample evidence
that estradiol enhances collagen over 45% (BMJ), a similar effect
for TTT is likely.
Vascular
aging slowed: TTT is good for endothelial cells, the gate keepers in
the artery walls thus preventing CVD Campelo et al., 2012, and Foresta et al., 2008 . Lowers blood pressure a
causal factor for CVD through nitrous oxide production Yue et al., 1995 and Nguyen et al., 2011 reduces arterial stiffness Yaron et al., 2009. Promotes production of prostaglandins, thus interfere
with vascular function via changes in the
thromboxane/COX pathway Cheuk et al., 2000; Song et al., 2004. For in depth summary article click
on link.
Testosterone
supplement and longevity, while
the literature fails to address this question in population studies, studies
have shown that those in the top 20% have lower rates of cancer, MI,
sarcopenia, etc., and this is strong indirect of its benefits, and thus
youthful level of TTT by logic would
be better, and this made all the more so by associated life-style changes. A
look at elderly weight lifters (obviously
on androgens) confirms this conclusion. The
protective effect for mitochondria results in life extension.
[1]
They are also healthful for women—see women body builders; however, most women
prefer estradiol with progesterone.
Testosterone (TTT) for women: Cognitive function: “Effects of testosterone on
visual-spatial performance has been suggested by enhanced performance in
females exposed prenatally to excess androgens.
Women with higher scores on mental status had
significantly higher total and bio-available testosterone levels.” (Moffat). In a study of women 55-88 years of age, those
with the higher levels of TTT
adjusted for age performed significantly
better. Sexual desire: “Compared with placebo, women
receiving the 300-µg/dL testosterone patch had significantly greater increases
from baseline in sexual
desire (67% vs 48%; P = .05) and in
frequency of satisfying sexual
activity (79% vs 43%; P = .049).” Vaginal estrogen creams and TTT reverse vaginal atrophy. Mood elevation: “The positive-well-being, depressed-mood, and composite
scores of the Psychological General Well-Being Index also improved at the higher dose”. Concern over
masculinization is misplaced: the dose is insufficient and dihydrotestosterone (not
TTT) is responsible for masculinization. Women body builders use a very
high dose of
androgens. Third reason in the 80’s and
90’s there was widely marketed, mainly in Europe, a formulation of HRT with TTT
(instead of progestin), still sold
in the US as Estratest. TTT
is natural for women since about
10% of their estradiol is converted to TTT
(and the converse for men producing estradiol). TTT
patch for women is available. See the 6 pages on
HRT for list of benefits,
especially for natural HRT of
estradiol and progesterone. If
wishing to increase muscle mass and sexual drive, I recommended for my wife 50
mgs pf TTT. Higher if she had
wanted to increase muscle mass, and half that, 25 mgs in a compounded
lotion for
hormonal replacement. Lotions supply
only about 10% of the sex hormones, and 30% vaginally.
Health,
testosterone like estradiol is taken for health benefits to slow the effects of
aging. Evolution to limit the burden of
the elderly causes a sharp drop in the levels of the sex steroids. Supplements
slows the decline. Unfortunately, our high sugar western diet
was not part of our evolutionary history, and the high amount of the reactive sugar
fructose (one half of the
disaccharide sucrose, table sugar) over taxes the cellular repair systems (autophagy)—journal
articles, Prof.
Robert
Lustig. This is the causes of the
conditions that are virtually unknown among those on aboriginal diets. Besides
HRT and low sugar diet, there is turning up autophagy by intermittent
fasting (skipping
breakfast) for which about 95% of adults will benefit—see and the video
library, Carbohydrates through insulin turn off
autophagy.
My beliefs
(not recommendations): Since 2004 at age of 61, I have used TTT
lotion from a compounding pharmacy.
Currently I am taking 4 times the
highest dose available in patented formulas[1],
and made even higher by improved absorption.
Only about 10% of topical TTT
passes through the skin with standard application, thus my 375 mg (2.5 gm at
15%) is equal to a 37.5 mg injection. I
apply TTT widely as possible
over the torso, back, shoulders, underarms, and face using water and rubbing it
in to increase absorption percentage.
I noticed from 15 years of use (as of 2019): cognitive &
mood benefits, increased energy, feeling well, resistance to weight gain,
improved muscle tone, tight abs, at first moderate increase in strength as to
weight load at the gym; and looking and feeling younger, thus TTT has sex romantic
benefits. My TTT
level averages the youthful 1,050 ng/dL, and my muscle tone is youthful. For financial
reasons Pharma offers limited effective doses.
Some doctors make a career out of hormone
balancing. I started at the age of
61 (2004) when my level of TTT 240
ng/dL (below 450 considered low, hypogonadism back then and should still be),
for which I was prescribed 10% dose 2 gram = 200 mgs). It was increased at the age of 68 to 2.5
grams, and from 10% to 15% at the age 70 (2013). A
daily 325 mg of aspirin uncoated lowers the risk of prostate cancer and other
cancers at least 50%
through the stimulation of the body’s apoptosis for destruction of abnormal
cells, at, and, and. In the feedback system, adding TTT lowers
testicular production of TTT and also sperm count. See Prof. Morgentaler supra, 145-7 for
discussion of this issues including possible reduction in testicular size. Oral
form of TTT taken long-term poses risk of liver damage. I have doubts about the modified TTT offered
in injections, but haven’t research its risks.
The TTT patch for over half
of users cause a skin rash/irritation—Androgel’s clinical trial submitted to
FDA. “Multiple studies of prostatic
hyperplasia (BPH) have failed to show that the size of the prostate enlarges
substantially with TTT therapy or
causes a diminution in urinary function,” Morgentaler supra 149. For above
reasons higher dose lotion of TTT, I have been using in my 7th
decade. In addition to TTT, I take since 2002 about 75 mg of DHEA, sublingually to avoid
95% first-pass metabolism by the liver. Sublingually it suppresses appetite
for an
hour (a diet aid). It has many health
benefits, is available in power from Amazon, is the most common of the bioactive
steroids made by the body, it declines like TTT and estradiol with age.
All three of the steroid and progesterone are neurosteroids made in the
brain by the glia cells and others for improved functions. As men enter their
6th decade by
design the steroids levels drop precipitously.
Low steroids are nature’s way of culling the burdensome elderly from the
village. Higher dose with age is needed
because of the reduced bioactivity as mitochondrial production of ATP declines,
and also because the receptors for steroids, like all protein receptors, become
less functional. Open your eyes and look
at the senior weight lifters; steroids are good for health, thus bad for
industries that profit from infirmities.
^^^^^^^^^^^^^ Non-technical summation^^^^^^^^^^^^^
Testosterone, what I have done: the male
hormone that is almost identical in structure to estrogen (estradiol) and thus
has many of the same benefits as estrogen.
Significant benefits for
testosterone: quality of life in 4
weeks, depressed mood in 30 weeks, bone mass in 26 weeks, lipid profile in 52,
inflammation in 12
weeks, sexual interest in 6 weeks, erection/ejaculate on in 26 weeks, red cells
in
52 weeks, insulin sensitivity in 52 weeks , muscle strength in 16 weeks,
fat mass in 16 weeks (Eur J Endocrinol. 2011). Other
benefits include improved cognitive
function, reduced risk for Alzheimer’s disease, metabolic syndrome, diabetes,
cardiovascular disease and the resultant heart attacks and strokes. The negative
claims made for testosterone is
from pharma’s marketing science. It is
not associated with higher cholesterol levels or prostate cancer, but rather
the reverse. “Testosterone does
not cause or produce deleterious effects on prostate cancer” Wiki,
2015.
When my serum TTT
level dropped below 450, in 2003, I started with 200 mg of
testosterone in a topical cream 10% from a compounding pharmacy. Commercial preparations are too weak. My ideal level is
850 to 1000 ng/dL. TTT
was increased to 3 grams in 2008 and 15% mg in 2013 at age 70, because
diminished--bio-receptors and response with age. Current assay methods are inaccurate
as to measure of free testosterone since it also includes DHEA. I apply TTT
as
widely as possible over the torso,
back, shoulders, underarms, and face, then using water and rubbing it in to
promote
better absorption. Doctors
who follow a program of hormone balance are milking the insurance and
patient. Pharma which is in the business
of treating illness and educating pill pusher, has convinced nearly all of them
that there are major risks with male HRT. A daily 325 mg of aspirin uncoated lowers
the risk of prostate cancer and other
cancers at least 50%
through the stimulation of the body’s necrosis factor for destruction of
abnormal cells, at, and, and. Oral form of TTT taken long-term poses
risk of liver damage. The TTT
patch for over half of users cause a skin rash/irritation. “Multiple studies of
prostatic hyperplasia (BPH) have failed to show that the size of the prostate
enlarges substantially with TTT
therapy or causes a diminution in urinary function,” Morgentaler supra
149. In addition to
TTT, I take since 2002 about 75 mg of DHEA, sublingually
to avoid 95% first-pass metabolism by the liver. Sublingually it suppresses
appetite for an
hour (a diet aid). It has many health
benefits, is available in power from Amazon, is the most common of the
steroids. It declines like TTT with
age, and is shown to extend quality life.
[1]
Androgel 1.62% in 5 gm = 81 mg. JK 2.5
gm at 15% = .375 gm daily is over 4 times that of Androgel. My testosterone
level is 1011 ng/dL. With the higher dose results gradually
improved as to appetite, mood excellent, weight constant without dieting, joint
pain vanished, strength increased about 15% over 5 years, physical endurance
and libido has steadily declined. I am
in the 7th decade.
|
GH, Growth hormone:
Sometimes used with TTT. “On
the other hand, most studies have
shown that administration of GH alone failed to improve muscle strength despite
amelioration of the detrimental somatic changes of aging. Both GH and TTT are
anabolic agents that promote muscle protein synthesis and hypertrophy but work
through separate mechanisms, and the combined administration of GH and TTT,
albeit in only a few studies, has resulted in greater efficacy than
either
hormone alone.” This is consistent with both
medical literature and belief held by body builders on “the
juice” (androgens & GH).
Further studies are needed to access the long-term consequences of the
combo of GH and TTT. GH must be injected. Alternates,
including enhancers are probably a scam.
If reputable lab studies aren’t done and published, expect the worse.
Possible the castrating of men with
terminal prostate cancer started with the use of estrogen in high doses which
has similar effect. See http://www.sciencedirect.com/science/article/pii/S0022534705636579
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Extended
footnote for web pages. Precocious puberty from Wikipedia:
TTT is made both by girls and boys,
pre-puberty. The FDA used 8 cases of reported aggression or genitalia
enlargement as the reason for the black-box warning. There was no
laboratory investigation to prove that those events were caused by father who
applied topical TTT. No proof was sought by the FDA, just anecdotal reports. Precocious sexual
develop occurs in a small number of children. In my class in 3rd grade,
for example, one girl was developing breasts. Moreover, the
patch, the most commonly sold form of TTT, is covered and adheres to the skin,
thus contact by the child would not occur. Finally,
if the source is a lotion from a compounding pharmacy (under 10% of total
sales), then transfer through contact is possible. But very few fathers take TTT, making such
transfer unlikely. Other relatives
would
have too infrequent contact. And
such
contact must be on the area applied, usually the underarm or chest.
But prolonged contact with these parts of the
body are high unlikely for a prepubescent boy. Moreover, casual contact would
not contribute appreciable to the level of TTT in the child.
If the FDA wanted to prove that transfer was
possible, they could easily construct a test with tagged TTT, and have 2nd
person rub against the person where the tagged TTT has been applied using a
topical lotion from a compounding pharmacy.
Then they would a day later take a blood sample and see what percentage
of TTT of total TTT is tagged. Without
testing the reports are not based on science.
The FDA simply relied upon 8 filings of reports the phenomena of either
aggression or genital enlargement in a prepubescent boy. The FDA made no effort to separate cases to
investigate the causes of precocious puberty, which has numerous natural
causes. A search of www.scholar.google.com list many of
such causes, and at the
bottom of page two a case study that could have been from exposure to
testosterone, though no causal nexus
was firmly
established, and the
authors were uncertain as to cause (published in an
obscure journal). Possible PhARMA
was
instrumental in generating those reports filed with the FDA through PhARMA
friendly physicians. The FDA doesn’t
issue black-bow warnings for block-buster drug on anecdotal evidence. Another hatchet
job done by PhARMA’s and the FDA on TTT—business as usual.
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Early menarche and
male sexual maturity: A
point of interest, and puzzle, has been not just the steady increase in height
over the last 2 centuries, but also the march toward younger age of menarche in
women and male sexual maturity, “In England, the average in 1840 was 16.5 years…. A
2006 study in Denmark found that puberty, as evidenced by breast development,
started at an average age of 9 years and 10 months, a year earlier than when a
similar study was done in 1991…. Early stages of male hypothalamic maturation
seem to be very similar to the early stages of female puberty, though occurring
about 1–2 years later.” see http://en.wikipedia.org/wiki/Puberty#Historical_shift.
Prostate cancer and TTT: Contrary to
accepted wisdom. It
has been long assumed that
testosterone stimulates the growth of prostate cancer; just like estrogen does
for breast cancer. It is standard
procedure to proscribe a drug that blocks testosterone (pharmaceutical
castration), the equivalent is done to women with breast cancer. This assumption is false.
Numerous
studies have instead of finding a negative effect for TTT (& estradiol for women)
find a positive TTT relation of lower risk and less aggressive.
The reason lies in the nature of cancer and
the approval process. Typical of
PhARMA
tests a chemotherapy on stage iv patients (terminal), find that extends their
life on an average around 2-3 months for FDA approval, then markets it for all
stages. However the majority of
stage
i-iii cancers are of the indolent type, and haven’t developed the ability to metastasize,
thus often the finding for terminal cancer cannot be validly extended. Moreover if it is aggressive and discovered in
an early stage, the outcome will is still the same. Survival for ng has minimal affect on
prognosis. Thus blocking sex hormones
has little benefit if metastatic, and if not hormone blocking increases long-term
mortality rate and lowers quality of life.
So too does operating on localized prostate cancer have little effect on
the course; “16 patients with localized prostate cancer
would
need to receive radical prostatectomy rather than watchful waiting in order to
prevent one death due to prostate cancer…. However, in men older than 65, there
was no statistically significant risk reduction even when adjusted for PSA
level, Gleason score and tumor stage.” (http://en.wikipedia.org/wiki/Prostate_cancer). Like
with lung cancer and other types, if it is
aggressive, finding it early makes little difference. Removing a cancer offers
a modest advantage, mainly
because over years an indolent can mutate to become aggressive—risk goes up
with time and number of indolent cancer cells.
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Falling TTT Levels since 1900: The normal level of testosterone for an 80
year old has steadily fallen since 1984 from 450 to under 250 in
2004. Three principle causes are
statins, polypharmacy (taking multiple drugs), & obesity. Moreover, estrogen
is known to reduce the
production of testosterone. There is an
assortment of evidence which show that estrogen mimics occupy estrogen
receptors and thereby cause both the reduction of the production of
testosterone and increase appetite (as though pregnant). Disconcerting is NIH
shift in standard for
low TTT and its affect upon medical practice.
The normal level for an 80 year old in 1984 (450 ng/dL), as high a
person aged 50 today, see Boston
study. The current
NIH’s
standard for low TTT is under200
ng/dL. “In the
meantime, truly hypogonadal men (those who are symptomatic men and have a serum
testosterone concentration below 200 ng/dL) who have no contraindications to
testosterone replacement therapy (e.g., prostate cancer) may benefit from
testosterone replacement regardless of whether they are 30 or 80 years of age.”
Over and over again the record
show that NIH acts in the interest of big PhARMA and contrary to the public’s
health. The negative position of NIH on
testosterone is one more example.
^^^^^^^^^^^^^^^^^^^^^^^^^^
GH, Growth hormone: Sometimes
used with TTT. “On the other hand, most studies have
shown that administration of GH alone failed to improve muscle strength despite
amelioration of the detrimental somatic changes of aging. Both GH and TTT are
anabolic agents that promote muscle protein synthesis and hypertrophy but work
through separate mechanisms, and the combined administration of GH and TTT,
albeit in only a few studies, has resulted in greater efficacy than
either
hormone alone.” This is consistent with both
medical literature and belief held by body builders on “the juice”
(androgens & GH).
Further studies are needed to access the long-term consequences of the
combo of GH and TTT. GH must be injected. Alternates,
including enhancers are probably a scam.
If reputable lab studies aren’t done and published, expect the worse.
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Extended
footnote for web pages. Precocious puberty from Wikipedia:
TTT is made both by girls and boys,
pre-puberty. The FDA used 8 cases of reported aggression or genitalia
enlargement as the reason for the black-box warning. There was no
laboratory investigation to prove that those events were caused by father who
applied topical TTT. No proof was sought by the FDA, just anecdotal reports. Precocious sexual
develop occurs in a small number of children. In my class in 3rd grade,
for example, one girl was developing breasts. Moreover, the
patch, the most commonly sold form of TTT, is covered and adheres to the skin,
thus contact by the child would not occur. Finally,
if the source is a lotion from a compounding pharmacy (under 10% of total
sales), then transfer through contact is possible. But very few fathers take
TTT, making such
transfer unlikely. Other relatives would
have too infrequent contact. And such
contact must be on the area applied, usually the underarm or chest. But prolonged
contact with these parts of the
body are high unlikely for a prepubescent boy. Moreover, casual contact would
not contribute appreciable to the level of TTT in the child. If the FDA wanted
to prove that transfer was
possible, they could easily construct a test with tagged TTT, and have 2nd
person rub against the person where the tagged TTT has been applied using a
topical lotion from a compounding pharmacy.
Then they would a day later take a blood sample and see what percentage
of TTT of total TTT is tagged. Without
testing the reports are not based on science.
The FDA simply relied upon 8 filings of reports the phenomena of either
aggression or genital enlargement in a prepubescent boy. The FDA made no effort
to separate cases to
investigate the causes of precocious puberty, which has numerous natural
causes. A search of www.scholar.google.com list many of
such causes, and at the
bottom of page two a case study that could have been from exposure to
testosterone, though no causal nexus
was firmly
established, and the
authors were uncertain as to cause (published in an
obscure journal). Possible PhARMA was
instrumental in generating those reports filed with the FDA through PhARMA
friendly physicians. The FDA doesn’t
issue black-bow warnings for block-buster drug on anecdotal evidence. Another hatchet
job done by PhARMA’s and the FDA on TTT—business as usual.
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Early menarche and
male sexual maturity: A
point of interest, and puzzle, has been not just the steady increase in height
over the last 2 centuries, but also the march toward younger age of menarche in
women and male sexual maturity, “In England, the average in 1840 was 16.5 years…. A
2006 study in Denmark found that puberty, as evidenced by breast development,
started at an average age of 9 years and 10 months, a year earlier than when a
similar study was done in 1991…. Early stages of male hypothalamic maturation
seem to be very similar to the early stages of female puberty, though occurring
about 1–2 years later.” see http://en.wikipedia.org/wiki/Puberty#Historical_shift.
Prostate cancer and TTT: Contrary to accepted wisdom. It has been
long assumed that
testosterone stimulates the growth of prostate cancer; just like estrogen does
for breast cancer. It is
standard procedure to proscribe a drug that blocks testosterone (pharmaceutical
castration), the equivalent is done to women with breast cancer. This assumption
is false. Numerous
studies have instead of finding a negative effect for TTT (& estradiol for
women) find a positive relation of lower risk and less aggressive. The reason
lies in the nature of cancer and
the approval process. Typical of PhARMA
tests a chemotherapy on stage iv patients (terminal), find that extends their
life on an average around 2-3 months for FDA approval, then markets it for all
stages. However the majority of stage
i-iii cancers are of the indolent type, and haven’t developed the ability to metastasize,
thus often the finding for terminal cancer cannot be validly extended. Moreover
if it is aggressive and discovered in
an early stage, the outcome will is still the same. Survival for ng has minimal
affect on
prognosis. Thus blocking sex hormones
has little benefit if metastatic, and if not hormone blocking increases long-term
mortality rate and lowers quality of life.
So too does operating on localized prostate cancer have little effect on
the course; “16 patients with localized prostate cancer would
need to receive radical prostatectomy rather than watchful waiting in order to
prevent one death due to prostate cancer…. However, in men older than 65, there
was no statistically significant risk reduction even when adjusted for PSA
level, Gleason score and tumor stage.” (http://en.wikipedia.org/wiki/Prostate_cancer). Like with
lung cancer and other types, if it is
aggressive, finding it early makes little difference. Removing a cancer offers
a modest advantage, mainly
because over years an indolent can mutate to become aggressive—risk goes up
with time and number of indolent cancer cells.
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Falling TTT Levels since 1900: The normal level
of testosterone for an 80
year old has steadily fallen since 1984 from 450 to under 250 in
2004. Three principle causes are
statins, polypharmacy (taking multiple drugs), & obesity. Moreover, estrogen
is no to reduced the
product of testosterone. There is an
assortment of evidence which show that estrogen mimics occupy estrogen
receptors and thereby cause both the reduction of the production of
testosterone and increase appetite (as though pregnant). Disconcerting is NIH
shift in standard for
low TTT and its affect upon medical practice.
The normal level for an 80 year old in 1984 (450 ng/dL), as high a
person aged 50 today, see Boston
study.
The current NIH’s
standard for low TTT is under200 ng/dL. “In the
meantime, truly hypogonadal men (those who are symptomatic men and have a serum
testosterone concentration below 200 ng/dL) who have no contraindications to
testosterone replacement therapy (e.g., prostate cancer) may benefit from
testosterone replacement regardless of whether they are 30 or 80 years of age.” Over and over again the record show that
NIH
acts in the interest of big PhARMA and contrary to the public’s health. The
negative position of NIH on testosterone
is one more example.
Lowering the level for normal for elderly: a way to get the doctors to not write scripts
More tricks beside
black bock warning and association with prostate cancer: NIH states that between
300 and 200 is
borderline hypogonadal, while under 200 should be treated. However, the average
level for an 80 year old
is 370 ng/dL. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686341/ which
is a very good article but for several
such pro-pharma spins. At http://jcem.endojournals.org/content/92/1/196.full
Average level of a 45 & 50 year old is
537, 60 years 517, and both 70 & 80 years
517 measured in 1987-89.
Inexplicable the levels dropped for the same group at intervals 1995-97
and 2002-04. The 50-year olds in 95-97
had level of485, the 60s at 476, and
the 70-80 at 471. However
the 2002-04 showed a major
decline. The 60s at 436, the 70s at 436, the 80s
at 368. Among causal factors is the increase in obesity and
polypharmacy over the course of follow-up. Counter is trend is a major
reduction in cigarette smoking. The
article noticed this: “Results were essentially unchanged when
all
covariate effects (see Subjects and Methods)
were included in multivariate. The chart
for 1919 shows the level to be 545 for an 80 year person. Plastic wear for foods
became popular in the
1970s. A number of sources find a connection to bisphenols and like compound
whose main source of exposure comes from food and water containers. “Bisphenol A
is an endocrine disruptor which
can mimic estrogen and
has been shown to cause negative health
effects in animal studies. More specifically, bisphenol A closely mimics the
structure and function of the hormone estradiol with
the ability to bind to and activate the same
estrogen receptor as the natural hormone… A 2011 rodent study found that
male rats exposed to BPA had lower sperm counts and testosterone levels than
those of unexposed males.” Wiki
At
http://jcem.endojournals.org/content/92/1/196.full http://jcem.endojournals.org/content/92/1/196.abstract
Massachusetts Male Aging Study (wave T1, T2, & T3) it
show those in 1987 to 1989, were over 2)% higher than the group tested in
1995-97; and T3 in 2002-2004 another drop of 20% mostly among those in the
75-80 age group. Thus in a 20 year
period the “normal (average) level of TTT dropped 40% among the elderly.
|